MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) — PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s…
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million,…
MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collaboration with Children’s Mercy Kansas…
Significant Enhancements to the Sequel II/IIe Platform Include Methylation Calling in Native DNA, Greatly Accelerated Sample Preparation, and Support for Gene Therapy Applications MENLO PARK, Calif., April 21, 2022 (GLOBE…
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results…
The Companies Will Leverage High-Throughput Whole Genome HiFi Sequencing for Advanced Plant Biotechnology, Breeding and Crop Protection Product Development MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ:…
Science Magazine Publication Details How the Human Genome was Finally Completed with the Help of PacBio Long-Read Technology MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB),…
Company Announces New European Headquarters to Serve Growing Customer Demand in Europe, Middle East and Africa Region Also Announces First Commercial Services Provider in Europe MENLO PARK, Calif., March 23,…
SickKids Will Use HiFi Sequencing to Explore Potential Genetic Causes of a Range of Medical and Developmental Conditions MENLO PARK, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — PacBio, a leading…
MENLO PARK, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…
Genomics Industry Veteran to Oversee Development of Robust Computational Biology Program MENLO PARK, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate…
PacBio HiFi Sequencing Technology Will Be Used to Investigate Effect on Diagnostic Yield of Unresolved Rare Diseases in Children SINGAPORE and MENLO PARK, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) —…
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. Updates since our last…
MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conferences: 11th Annual SVB Leerink Global Healthcare…
MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.